Drug & Medication Database

Dosage form: POWDER. Active ingredients: METHYLPREDNISOLONE HEMISUCCINATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: METHYLPREDNISOLONE HEMISUCCINATE (1 kg/kg). Category: BULK INGREDIENT.

DESCRIPTION SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone.

Brands: Solu-medrol

Dosage form: POWDER. Active ingredients: METHYLPREDNISOLONE SULEPTANATE (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Dosage form: POWDER. Active ingredients: METHYLPREDNISOLONE SULEPTANATE (1 kg/kg). Category: BULK INGREDIENT.

The product, made from naturally derivedsafesurfactants, effectively maintains cleanliness and moisturein the external genital area, providingarefreshing cleansing sensation without causing irritation

Brands: Lesonel Forming Feminine Wash

DESCRIPTION METHITEST™ (methyltestosterone) tablets, USP contain methyltestosterone USP, a synthetic androgen. Androgens are steroids that develop and maintain primary and secondary male sex characteristics. METHITEST™ (methyltestosterone) tablets, USP are to be taken orally. Androgens are derivatives of cyclopentanoperhydrophenanthrena. Endogenous androgens are C-19 steroids with a side chain at C-17, and with two angular methyl groups. Testosterone is the primary endogenous androgen.

Brands: Methitest

Dosage form: POWDER. Active ingredients: METHYLTESTOSTERONE (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Manufactured by ROCHE. Dosage form: TABLET. Route: ORAL. Active ingredients: METHYPRYLON (50MG). Application: NDA009660.

Manufactured by NOVARTIS. Dosage form: TABLET. Route: ORAL. Active ingredients: METHYSERGIDE MALEATE (2MG). Application: NDA012516.

Manufactured by BAUSCH AND LOMB. Dosage form: SOLUTION/DROPS. Route: OPHTHALMIC. Active ingredients: METIPRANOLOL HYDROCHLORIDE (0.3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA019907.

11 DESCRIPTION Metoclopramide hydrochloride, the active ingredient in Metoclopramide Tablets USP, is a dopamine-2 receptor antagonist. Metoclopramide hydrochloride (metoclopramide monohydrochloride monohydrate) is a white crystalline, odorless substance, freely soluble in water. Its chemical name is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy benzamide monohydrochloride monohydrate. The molecular formula is C 14 H 22 ClN 3 O 2 •HCl•H 2 O. Its molecular weight is 354.3.

Brands: Metoclopramide

11 DESCRIPTION Metoclopramide hydrochloride, the active ingredient in GIMOTI, is a dopamine-2 receptor antagonist. Metoclopramide hydrochloride is a white, crystalline, odorless substance, freely soluble in water. Its chemical name is 4-amino­-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy benzamide monohydrochloride monohydrate. The molecular formula is C 14 H 22 ClN 3 O 2 ∙HCl∙H 2 O. Its molecular weight is 354.3.

Brands: Gimoti

Dosage form: POWDER. Active ingredients: METOCLOPRAMIDE HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Manufactured by QUAD PHARMS. Dosage form: Injectable. Route: Injection. Active ingredients: METOCURINE IODIDE (2MG/ML). Application: ANDA089443.

DESCRIPTION Metolazone Tablets, USP for oral administration contain 2.5 mg, 5 mg or 10 mg of metolazone, USP, a diuretic/saluretic/antihypertensive drug of the quinazoline class. Metolazone has the molecular formula C 16 H 16 ClN 3 O 3 S, the chemical name 7-chloro-1, 2, 3, 4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide, and a molecular weight of 365.83.

Brands: Metolazone

Dosage form: POWDER. Active ingredients: METOPIMAZINE (100 kg/100kg). Category: BULK INGREDIENT.

11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, USP a selective beta 1 -adrenoreceptor blocking agent. Metoprolol tartrate, USP is (±)-1-(Isopropylamino)-3-[p-(2-methoxyethyl) phenoxy]-2-propanol L-(+)­tartrate (2:1) salt, and its structural formula is Metoprolol tartrate, USP is a white, practically odorless, crystalline powder with a molecular weight of 684.82.

Brands: Metoprolol Tartrate

Manufactured by NOVARTIS. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: METOPROLOL FUMARATE (EQ 200MG TARTRATE). Application: NDA019786.

11 DESCRIPTION TOPROL-XL, metoprolol succinate, is a beta 1 -selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of metoprolol for once-daily administration. The tablets comprise a multiple unit system containing metoprolol succinate in a multitude of controlled release pellets.

Brands: Toprol Xl

Metoprolol succinate, is a beta 1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. Metoprolol succinate extended-release tablets has been formulated to provide a controlled and predictable release of metoprolol for once-daily administration. The tablets comprise a multiple unit system containing metoprolol succinate in a multitude of controlled release pellets.

Brands: Metoprolol Succinate Er

Metoprolol succinate ER tablets are a beta-1 selective adrenergic blocker in extended-release form indicated for treating hypertension, angina pectoris, and heart failure.

Brands: Metoprolol Succinate

11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. Metoprolol tartrate is (±)-1-(Isopropylamino)-3-[p-(2-methoxyethyl) phenoxy]-2-propanol L-(+)-tartrate (2:1) salt, and its structural formula is Metoprolol tartrate, USP is a white, crystalline powder with a molecular weight of 684.82.

Brands: Metoprolol Tartrate

11 DESCRIPTION Metoprolol tartrate and hydrochlorothiazide tablets, USP has the antihypertensive effect of metoprolol tartrate, a beta adrenoreceptor blocker, and hydrochlorothiazide, a thiazide diruetic. It is available as tablets for oral administration. The 50/25 tablets contain 50 mg of metoprolol tartrate USP and 25 mg of hydrochlorothiazide USP and the 100/25 tablets contain 100 mg of metoprolol tartrate USP and 25 mg of hydrochlorothiazide USP.

Brands: Metoprolol Tartrate And Hydrochlorothiazide

Dosage form: POWDER. Active ingredients: METOPROLOL TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Metoprolol Tartrate Injection, USP is a selective beta 1 -adrenoreceptor blocking agent, available in 5 mL and oversized 10 mL vials for intravenous administration. Each vial contains a sterile solution of Metoprolol Tartrate USP, 5 mg, and Sodium Chloride, USP, 45 mg, and Water for Injection, USP.

Brands: Metoprolol Tartrate

11 DESCRIPTION MYALEPT (metreleptin) for injection is a recombinant human leptin analog for injection that binds to and activates the leptin receptor. Metreleptin (recombinant methionyl-human leptin) is produced in E. coli and differs from native human leptin by the addition of a methionine residue at its amino terminus. Metreleptin is a 147-amino acid, nonglycosylated, polypeptide with one disulfide bond between Cys-97 and Cys-147 and a molecular weight of approximately 16.15 kDa.

Brands: Myalept

Manufactured by GE HEALTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: METRIZAMIDE (3.75GM/VIAL). Application: NDA017982.

Manufactured by GE HEALTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CALCIUM METRIZOATE (0.78MG/ML); MEGLUMINE METRIZOATE (75.9MG/ML); METRIZOATE MAGNESIUM (0.15MG/ML); METRIZOATE SODIUM (16.6MG/ML). Application: NDA016847.

Manufactured by GE HEALTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CALCIUM METRIZOATE (0.78MG/ML); MEGLUMINE METRIZOATE (75.9MG/ML); METRIZOATE MAGNESIUM (0.15MG/ML); METRIZOATE SODIUM (16.6MG/ML). Application: NDA016847.